Laurion Capital Management »

Enanta Pharmaceuticals shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $126k 11k 11.17
2020-06-30 $411k 8.2k 50.26
2019-12-31 $377k 6.1k 61.80

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Abbvie Put Option (ABBV)
Blackrock (BLK)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Goldman Sachs (GS)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Strategy Cl A New Call Option (MSTR)
International Business Machines (IBM)
NVIDIA Corporation Call Option (NVDA)
Honeywell International (HON)

View all positions for Laurion Capital Management

Top funds holding Enanta Pharmaceuticals

Vanguard Group
Farallon Capital Management
Krensavage Asset Management
Henderson Group
BlackRock
Millennium Management
Acadian Asset Management
Commodore Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Stonepine Capital Management
Point72 Asset Management
Marshall Wace
Dimensional Fund Advisors

View all funds holding Enanta Pharmaceuticals